autologous ET1402L1-CART cells
ETCH17AFPCAR101
Phase 1 mab terminated
Quick answer
autologous ET1402L1-CART cells for Hepatocellular Carcinoma is a Phase 1 program (mab) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AEON Biopharma
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated